Friday, June 30, 2017, after two years, MINSA has issued a new regulation of clinical studies, through D.S. No. 021-2017-SA which replaces Supreme Decree No. 017-2006-SA and repeals D.S. N ° 020-2015-SA established the moratorium on clinical studies in the pediatric…
FOMAT AT DIA 2017
GAMES, PANAMA HATS, COFFEE, CHOCOLATE & CLINICAL RESEARCH DIVERSITY AT DIA 2017 From June 19th to the 21st FOMAT Medical Research hosted booth #958 at the DIA Meeting 2017 in Chicago, IL. FOMAT Medical Research is always looking for ways to…
The Best Places outside U.S. to Run Clinical Trials According to their Regulatory Times
The increasing trend toward conducting clinical trials outside the United States is an important consideration in discussing ways to improve the efficiency of trials. The number of patients enrolled in clinical trials is decreasing in the United States and increasing abroad….
Clinical Trials in Latin America – Challenges and Opportunities
Latin America has become a great ally for clinicians when developing Clinical Trials. This region provides many advantages and facilities other regions just can’t match. With over 20 countries spanning from Mexico in North America to Chile and Argentina in the South….
5 Barriers you’ll Have to Face while Diversifying Clinical Trials
Minority participation in clinical trials is an important topic in public health discussions. This representation touches on issues of equality and the elimination of disparities, which are core values of the field. The FDA Safety and Innovation Act introduced in 2012,…
6 Reasons to Diversify Clinical Trials
Starting from the fact that minorities account for fewer than 10 percent of patients enrolled in clinical trials. Health disparities and underrepresentation in clinical trials could become a serious issue in the upcoming years. FDA Regulations In 2012 Congress included Section…
Psoriatic Arthritis Drug Shows Promise in Phase 3 Trial
In a pivotal phase-3 clinical trial led by a Stanford University School of Medicine investigator, patients with psoriatic arthritis for whom standard-of-care pharmaceutical treatments have provided no lasting relief experienced a significant reduction in symptoms, including joint tenderness and swelling, when…
Clinical Trials Diversity – More Minorities Needed to Make Research Relevant to All
Minorities, in fact, account for fewer than 10 percent of patients enrolled in clinical trials, according to the National Institutes of Health (NIH) National Institute on Minority Health and Health Disparities. Today, Wilkins brings together academic researchers and community members to…
Clinical Research in Ecuador | Diversity in Hispanic Community Involvement
Why Is Diversity Important? FDA Action Plan In 2012 the Food and Drug Administration Safety and Innovation Act was published. Most of this FDA Action plan is based to encourage researchers to include safety and effectiveness data by demographic subgroups, including…